Pregabalin Capsule
Product Images NDC 71610-997

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71610-997). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0997 30)

This is a description for a medication called Pregabalin in 200mg strength with 30 capsules. The manufacturer is ScieGen Pharmaceuticals Inc., and it is packaged by Alphons Pharms in Cookeville, H. The text also mentions a warning to keep all drugs out of the reach of children due to potential habit-forming properties.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Figure 1 (Pregabalin Fig01)

FDA Label Image

Figure 2 (Pregabalin Fig02)

This text provides information on the percent improvement in pain for patients taking Pregabalin 160 mg for three days. The data includes various percentages ranging from 2% to 100% to indicate the level of improvement in pain experienced by the patients.*

FDA Label Image

Figure 3 (Pregabalin Fig03)

FDA Label Image

Figure 4 (Pregabalin Fig04)

This text describes the improvement of parent patients after being prescribed Pregabalin at different dosages and a placebo. It mentions the frequency of dosage and indicates the levels of pain improvement from the baseline.*

FDA Label Image

Figure 5 (Pregabalin Fig05)

This text presents a comparison of the effectiveness of different medications, including Pregabalin and Placebo, on patient improvement based on Pain improvement from Baseline. It indicates doses like 100 mg three times a day for Pregabalin and 80 mg three times a day. The results show a patient's improvement breakdown for each treatment.*

FDA Label Image

Figure 6 (Pregabalin Fig06)

The text appears to be a comparison between different dosages of a drug and a placebo in a study. The dosages studied are 0mg, 50mg/day, 150mg/day, 300mg/day, and 600mg/day. It mentions a statistically significant difference compared to the placebo. This information could be related to the effectiveness or side effects of the drug at different doses.*

FDA Label Image

Figure 7 (Pregabalin Fig07)

FDA Label Image

Figure 9 (Pregabalin Fig08)

This text presents data on the percentage of patients improved based on different daily doses of Pregabalin. It shows the comparison between Pregabalin doses of 300mg and 450mg daily, as well as a placebo group. The information also includes the percent improvement in pain from baseline.*

FDA Label Image

Figure 10 (Pregabalin Fig09)

FDA Label Image

Figure 11 (Pregabalin Fig10)

FDA Label Image

Figure 12 (Pregabalin Fig11)

This text displays a data table showing the percentage of subjects improved over time, with values ranging from 100 to 280. It includes information on the percentage of improvement from baseline to Week 16 for two groups - Pregabalin and Placebo.*

FDA Label Image

Figure 13 (Pregabalin Fig13)

This text provides data on responder rates (%) for different treatments. The rates listed are 40.6%, 29.1%, and 22.6%. It also mentions a placebo treatment at doses of 2.5 mg/kg/day and 10 mg/kg/day. The information on responder rates and treatments can be useful for analyzing the effectiveness of the treatments in a study or clinical trial.*

FDA Label Image

Cockcroft And Gault Equation (Pregabalin Formula)

This text provides a formula to calculate creatinine clearance (CLCT) for individuals based on their age, weight, gender, and serum creatinine level. The formula involves subtracting 140 from the person's age, multiplying this result by their weight in kilograms, and then multiplying by 0.85 for female patients. Finally, this value is multiplied by the serum creatinine level in mg/dL to obtain the creatinine clearance value.*

FDA Label Image

Chemical Structure (Pregabalin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.